12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Annexon (NASDAQ:ANNX) shares increased by 57.2% to $7.2 during Tuesday’s pre-market session. The market value of their…
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers MyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday’s after-market session. The market value of their…
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Rezolute (NASDAQ:RZLT) stock increased by 52.7% to $4.58 during Tuesday’s after-market session. The company’s market cap stands…
PharmaCyte Biotech Makes $7M Investment In MyMD Pharmaceuticals; Investment In Life Sciences Solidifies Previously Announced Strategy To Utilize Significant Cash Position To Create Additional Stockholder Value
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
MyMD Pharmaceuticals Filing From Late Monday Shows Co. Entered Omnibus Waiver And Amendment Agreement With Required Holders Under Previously Announced Securities Purchase Agreement
As previously disclosed, on February 21, 2023, MyMD Pharmaceuticals, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain accredited investors (the "Holders") pursuant
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.3% to $10.19 during Tuesday’s pre-market session. The market value…
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.
MyMD Pharmaceuticals Announces 1-For-30 Reverse Stock Split To Maintain Nasdaq Listing
Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company committed to developing
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers MyMD Pharmaceuticals (NASDAQ:MYMD) shares increased by 9.3% to $0.15 during Thursday’s after-market session. The market value of…